Skip to content

A study to test how BI 3031185 is tolerated by people with borderline personality disorder or attention-deficit/hyperactivity disorder.

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-514296-17-00
Acronym
1516-0003
Enrollment
96
Registered
2025-03-13
Start date
2025-08-05
Completion date
Unknown
Last updated
2025-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder, Borderline personality disorder

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026